High

Step 1: The sentiment in the management's discussion regarding McKesson Corporation is cautiously optimistic, recognizing the challenges posed by the COVID-19 pandemic. They discuss the impacts of COVID-19 on their business operations and financial performance, including a decrease in pharmaceutical distribution volumes earlier due to the global economic environment and pandemic-related restrictions. They also detail their efforts to support the distribution of COVID-19 vaccines and ancillary supplies.

Step 2: The financial indicators provided in the discussion highlight significant impacts on the company's performance:
- Gross profit increased due to sales of COVID-19 tests.
- Operating expenses included charges related to opioid-related claims, impaired assets, and charges associated with certain liabilities.
- Charges for impairment of long-lived assets.
- Charges related to COVID-19 including inventory impairments and excess inventory in the Medical-Surgical Solutions segment.
- A dilution in loss per common share due to various charges and separations.

Step 3: The company faced challenges due to the COVID-19 pandemic, experiencing fluctuations in pharmaceutical distribution volumes, impacts from decreased demand in various segments, and increases in operating costs related to safety measures and managing pandemic-related demands. The company's revenue growth was primarily driven by market growth in the U.S. Pharmaceutical segment, while facing adverse impacts from COVID-19.

Step 4: High risk of bankruptcy. The significant impacts of the COVID-19 pandemic on McKesson Corporation's business operations, financial results, and liquidity, as highlighted in the provided text, present a high risk of bankruptcy. The company faced challenges in revenue generation, incurred substantial expenses related to COVID-19, opioid-related liabilities, impairments, and experienced fluctuations in demand and supply chain disruptions. These factors, coupled with the uncertainties surrounding the duration and spread of the virus, contribute to the high risk of bankruptcy for McKesson Corporation.